Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
Drug Nomenclature01:17

Drug Nomenclature

1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

592
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
592
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging Fragmented PHR Ecosystems Through a Unified Document Terminology.

Studies in health technology and informatics·2026
Same author

Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study).

Therapeutic advances in infectious disease·2026
Same author

Research capacity and decolonisation in Sub-Saharan Africa: a bibliometric analysis.

BMJ global health·2026
Same author

Development and evaluation of a whole-virus ELISA for severe fever with thrombocytopenia syndrome virus: Comparison with a recombinant nucleocapsid protein ELISA.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2026
Same author

Detection of novel orthonairovirus and unclassified flavivirus in Rhipicephalus appendiculatus ticks in Kenya.

Acta tropica·2026
Same author

Efficacy of Osteoporosis Treatment in Nonagenarians With Proximal Femoral Fractures: A Retrospective Cohort Study.

Cureus·2025

Related Experiment Video

Updated: Jun 7, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

504

Mapping Drug Terms via Integration of a Retrieval-Augmented Generation Algorithm with a Large Language Model.

Eizen Kimura1, Yukinobu Kawakami1, Shingo Inoue2

  • 1Department of Medical Informatics, Medical School of Ehime University, Toon, Ehime, Japan.

Healthcare Informatics Research
|November 17, 2024
PubMed
Summary

Integrating retrieval-augmented generation (RAG) with large language models (LLMs) significantly improves drug name mapping accuracy across international vocabularies, outperforming traditional methods.

Keywords:
Computer Neural NetworkControlled VocabularyMachine LearningRxNormTerminology

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

Related Experiment Videos

Last Updated: Jun 7, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

504
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

Area of Science:

  • Pharmacoinformatics
  • Natural Language Processing
  • Computational Linguistics

Background:

  • Accurate drug name mapping across international vocabularies is crucial for global pharmaceutical data interoperability.
  • Traditional methods like string comparison and vector similarity face challenges in handling linguistic variations and complex drug names.

Purpose of the Study:

  • To evaluate the efficacy of integrating retrieval-augmented generation (RAG) and large language models (LLMs) for enhanced drug name mapping.
  • To compare the performance of RAG-enhanced LLMs against conventional vector similarity techniques.

Main Methods:

  • Drug ingredient names were translated from Japanese to English.
  • Drug concepts were extracted from OHDSI vocabulary and mapped to RxNorm using vector similarity (BioBERT embeddings) as a baseline.
  • Large language models integrated with RAG were developed to refine candidate selection.
  • Performance was assessed by comparing RAG-LLM efficacy against baseline vector similarity methods.

Main Results:

  • The combined LLM + RAG approach significantly outperformed traditional vector similarity methods.
  • Hit rates for Mixtral 8x7b and GPT-3.5 models exceeded 90%, compared to a baseline of 64%.
  • R-precision improved from 23% (baseline) to 41%-50% with LLM + RAG, indicating better alignment with human evaluation.

Conclusions:

  • Integrating RAG with LLMs offers a superior method for drug name mapping compared to conventional techniques.
  • This approach provides a more refined and accurate solution for global drug information mapping.